A CLINICAL AND IMMUNOLOGICAL STUDY ON THE THYMOPEPTIDE THERAPY FOR CHRONIC LIVER DISEASE

The second Affiliated Hospital; Zhen Meizhen et al

doi:10.13406/j.cnki.cyxb.1986.01.001

您当前的位置：

首页 >

文章列表页 >

A CLINICAL AND IMMUNOLOGICAL STUDY ON THE THYMOPEPTIDE THERAPY FOR CHRONIC LIVER DISEASE

更新时间：2024-01-17

- A CLINICAL AND IMMUNOLOGICAL STUDY ON THE THYMOPEPTIDE THERAPY FOR CHRONIC LIVER DISEASE
- Journal of Chongqing Medical University Issue 1, Pages: 1-4(1986)
- 作者机构：
  
  1. 重庆医科大学第二医院肝炎研究室
  2. 卫生部长春生物制品所
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.1986.01.001
  CLC：
- Published：1986，
扫描看全文
[1]郑美贞,张定凤,邹淑碧,赵有蓉,张全海,周亚苏,米桢栋.胸腺肽静脉注射治疗慢性肝病临床与免疫学疗效的近期观察[J].重庆医科大学学报,1986(01):1-4.

The second Affiliated Hospital, Zhen Meizhen et al. A CLINICAL AND IMMUNOLOGICAL STUDY ON THE THYMOPEPTIDE THERAPY FOR CHRONIC LIVER DISEASE. [J]. Journal of Chongqing Medical University (1):1-4(1986)
[1]郑美贞,张定凤,邹淑碧,赵有蓉,张全海,周亚苏,米桢栋.胸腺肽静脉注射治疗慢性肝病临床与免疫学疗效的近期观察[J].重庆医科大学学报,1986(01):1-4. DOI： 10.13406/j.cnki.cyxb.1986.01.001.

The second Affiliated Hospital, Zhen Meizhen et al. A CLINICAL AND IMMUNOLOGICAL STUDY ON THE THYMOPEPTIDE THERAPY FOR CHRONIC LIVER DISEASE. [J]. Journal of Chongqing Medical University (1):1-4(1986) DOI： 10.13406/j.cnki.cyxb.1986.01.001.

摘要

本文报道采用国产胸腺肽治疗24例慢性乙型肝炎患者的结果。剂量为每次6—8mg

每日1次疗程3个月。另设齐墩果酸（对照组）作比较。结果

用药后治疗组SGPT下降的显效率为92%

对照组为41.5%。对SB下降至正常

二组分别为100%及33%。所以

从临床疗效看治疗组优于对照组

提示胸腺肽是治疗慢性乙型肝炎的一种有前途的药品

它可能通过提高抑制性细胞活性

从而对乙肝自身免疫反应及病情恢复具有重要的作用。

Abstract

Twenty four cases of chronic hepatitis were treated with thymopeptide and compared with 24 controlled cases. The results revealed that in thymopeptide group the effective rate was 83.3%

whereas in the control group the effective rate was only 29.2%(P<0.01) . The number of the patients in both group whose SGPT were returned to normal was different (P<0.05) ; and SB decreased to normal level was 100% and 33% respectively (P<0.05) .The authors believed that the thymopeptide probably increased the activity of the TS cell so that it can improve the course of the disease. Obviously

these results showed that there was a significant difference between the study group anp controlled group. It seems that the thymopeptide may be a more effective drug

关键词

胸腺肽慢性肝炎

Keywords

ThymopetideChronic hepatitis

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The relationship between liver pathologic histology and levels of serum HBV-DNA,ALT in patients with chronic hepatitis B

The therapeutic effects comparison between plasma exchange and hemoperfusion in treating pattents of thronic hepatitis with hyperbilirubinemia

The therapeutic effects comparison between one and two hemoperfusion in treatment of chronic hepatitis with hyperbilirubinemia

Related Author

JIANG Yongfang

et al

ZHANG Li-dan

et al

石小枫

LANG Qing

et al

戚敬虎

Related Institution

Center for Liver Disease,the Second Xiangya Hospital,Central South University

湖南省衡山县人民医院内科

Department of Infection,the Second Affiliated Hospital,Chongqing Medial University

Department of Infection,the Second Affiliated Hospital,Chongqing Medical University

⁰